BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28365229)

  • 21. In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells.
    Alcocer-González JM; Berumen J; Taméz-Guerra R; Bermúdez-Morales V; Peralta-Zaragoza O; Hernández-Pando R; Moreno J; Gariglio P; Madrid-Marina V
    Viral Immunol; 2006; 19(3):481-91. PubMed ID: 16987066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer.
    Sasagawa T; Takagi H; Makinoda S
    J Infect Chemother; 2012 Dec; 18(6):807-15. PubMed ID: 23117294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune evasion in human papillomavirus-associated cervical cancer.
    Tindle RW
    Nat Rev Cancer; 2002 Jan; 2(1):59-65. PubMed ID: 11902586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFN-gamma produced by human papilloma virus-18 E6-specific CD4+ T cells predicts the clinical outcome after surgery in patients with high-grade cervical lesions.
    Seresini S; Origoni M; Lillo F; Caputo L; Paganoni AM; Vantini S; Longhi R; Taccagni G; Ferrari A; Doglioni C; Secchi P; Protti MP
    J Immunol; 2007 Nov; 179(10):7176-83. PubMed ID: 17982110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
    Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
    J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.
    Nonn M; Schinz M; Zumbach K; Pawlita M; Schneider A; Dürst M; Kaufmann AM
    J Cancer Res Clin Oncol; 2003 Sep; 129(9):511-20. PubMed ID: 12905010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unexpectedly large polyclonal repertoire of HPV-specific T cells is poised for action in patients with cervical cancer.
    de Vos van Steenwijk PJ; Heusinkveld M; Ramwadhdoebe TH; Löwik MJ; van der Hulst JM; Goedemans R; Piersma SJ; Kenter GG; van der Burg SH
    Cancer Res; 2010 Apr; 70(7):2707-17. PubMed ID: 20233872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape.
    Conesa-Zamora P
    Gynecol Oncol; 2013 Nov; 131(2):480-8. PubMed ID: 23994536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of IL-10 in immune suppression in cervical cancer.
    Bhairavabhotla RK; Verm V; Tongaonkar H; Shastri S; Dinshaw K; Chiplunkar S
    Indian J Biochem Biophys; 2007 Oct; 44(5):350-6. PubMed ID: 18341210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract.
    Jimenez-Flores R; Mendez-Cruz R; Ojeda-Ortiz J; Muñoz-Molina R; Balderas-Carrillo O; de la Luz Diaz-Soberanes M; Lebecque S; Saeland S; Daneri-Navarro A; Garcia-Carranca A; Ullrich SE; Flores-Romo L
    Immunology; 2006 Feb; 117(2):220-8. PubMed ID: 16423058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical status and expression of HPV genes in cervical cancers.
    Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
    Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5'-segment of the upstream regulatory region (URR).
    Arany I; Grattendick KG; Tyring SK
    Antiviral Res; 2002 Aug; 55(2):331-9. PubMed ID: 12103433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.
    Welters MJ; de Jong A; van den Eeden SJ; van der Hulst JM; Kwappenberg KM; Hassane S; Franken KL; Drijfhout JW; Fleuren GJ; Kenter G; Melief CJ; Offringa R; van der Burg SH
    Cancer Res; 2003 Feb; 63(3):636-41. PubMed ID: 12566307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.
    Berger KL; Barriga F; Lace MJ; Turek LP; Zamba GJ; Domann FE; Lee JH; Klingelhutz AJ
    Virology; 2006 Dec 5-20; 356(1-2):68-78. PubMed ID: 16945398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.
    Caberg JH; Hubert PM; Begon DY; Herfs MF; Roncarati PJ; Boniver JJ; Delvenne PO
    Carcinogenesis; 2008 Jul; 29(7):1441-7. PubMed ID: 18566017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease-stage variance in functional CD4(+) T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes.
    Warrino DE; Olson WC; Knapp WT; Scarrow MI; D'Ambrosio-Brennan LJ; Guido RS; Edwards RP; Kast WM; Storkus WJ
    Clin Cancer Res; 2004 May; 10(10):3301-8. PubMed ID: 15161683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of cell cycles is of key importance in human papillomavirus (HPV)-associated cervical carcinogenesis.
    Brenna SM; Syrjänen KJ
    Sao Paulo Med J; 2003 May; 121(3):128-32. PubMed ID: 12920476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the HPV integration and its progression to cervical cancer.
    Oyervides-Muñoz MA; Pérez-Maya AA; Rodríguez-Gutiérrez HF; Gómez-Macias GS; Fajardo-Ramírez OR; Treviño V; Barrera-Saldaña HA; Garza-Rodríguez ML
    Infect Genet Evol; 2018 Jul; 61():134-144. PubMed ID: 29518579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.
    Han S; Wang Y; Shi X; Zong L; Liu L; Zhang J; Qian Q; Jin J; Ma Y; Cui B; Yang X; Kong B; Zhang Y
    Exp Cell Res; 2018 Oct; 371(1):222-230. PubMed ID: 30099052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOBEC-mediated genomic alterations link immunity and viral infection during human papillomavirus-driven cervical carcinogenesis.
    Chen L; Qiu X; Zhang N; Wang Y; Wang M; Li D; Wang L; Du Y
    Biosci Trends; 2017 Sep; 11(4):383-388. PubMed ID: 28717061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.